Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes

  • Published:
Surgical Endoscopy And Other Interventional Techniques Aims and scope Submit manuscript

Abstract

Background

There is increasing experience with laparoscopic radiofrequency ablation for the treatment of patients with hepatic metastasis from colorectal and neuroendocrine cancer and those with hepatocellular cancer. Little is known about the outcomes for patients with other tumor types.

Methods

Between January 1996 and March 2005, 517 patients with 1,500 primary and metastatic liver tumors underwent laparoscopic radiofrequency ablation. Among these, 53 patients (10%) had cancers other than the colorectal, neuroendocrine, or hepatocellular types including sarcoma (n = 18), breast cancer (n = 10), esophagus cancer (n = 4), melanoma (n = 4), lung cancer (n = 3), ovarian cancer (n = 2), pancreas cancer (n = 2), unknown primary cancer (n = 2), cholangiocarcinoma (n = 2), rectal squamous cancer (n = 2), renal cancer (n = 2), papillary thyroid cancer (n = 1), and hemangioendothelioma (n = 1). Unlike the criteria for treatment of the more usual tumor types, these patients had a diagnosis of liver-exclusive disease, as diagnosed by preoperative imaging. They also had failed chemotherapy.

Results

The 53 patients underwent ablation of 192 lesions, with 8 patients undergoing repeat treatment. The hospital stay averaged 1 day, and there was no 30-day mortality. Complications included one postoperative hemorrhage, one liver abscess, and one wound infection. Tumors recurred locally for 17% of the lesions over a mean follow-up period of 24 months. The overall median survival was 33 months for the whole series, more than 51 months for breast cancer, and 25 months for sarcoma.

Conclusion

Laparoscopic radiofrequency ablation can safely and effectively treat hepatic metastasis of these unusual tumor types. The authors believe that this heterogeneous group of patients, selected for their unusual presentation of liver-exclusive disease, may benefit from cytoreduction of their tumor by laparoscopic radiofrequency ablation when other treatment methods have failed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Berber E, Flesher N, Siperstein AE (2002) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 26: 985–990

    Article  PubMed  Google Scholar 

  2. Berber E, Flesher NL, Siperstein AE (2000) Initial clinical evaluation of the RITA 5-centimeter radiofrequency thermal ablation catheter in the treatment of liver tumors. Cancer J Sci Am 6: S319–S329

    Google Scholar 

  3. Berber E, Pelley R, Siperstein AE (2005) Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23: 1358–1364

    Article  PubMed  Google Scholar 

  4. Berber E, Rogers S, Siperstein A (2005) Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg Endosc 19: 710–714

    Article  PubMed  CAS  Google Scholar 

  5. Berber E, Siperstein A (2004) Laparoscopic radiofrequency ablation of liver tumors. In: Ellis LM, Curley SA, Tanabe KK (eds) Radiofrequency ablation for cancer: current indications, techniques and outcome. Springer-Verlag, New York pp 77–88

    Google Scholar 

  6. Bowles BJ, Machi J, Limm WM, Severino R, Oishi AJ, Furumoto NL, Wong LL, Oishi RH (2001) Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 136: 864–869

    PubMed  CAS  Google Scholar 

  7. Chen H, Pruitt A, Nicol TL, Gorgulu S, Choti MA (1998) Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 2: 151–155

    Article  PubMed  CAS  Google Scholar 

  8. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients [see comments]. Ann Surg 230: 1–8

    Article  PubMed  CAS  Google Scholar 

  9. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234: 540–547, discussion 547–548

    Article  PubMed  CAS  Google Scholar 

  10. Di Carlo I, Grasso G, Patane D, Russello D, Latteri F (2003) Liver metastases from lung cancer: is surgical resection justified? Ann Thorac Surg 76: 291–293

    Article  PubMed  Google Scholar 

  11. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185: 158–164

    Article  PubMed  Google Scholar 

  12. Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME (1999) Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 10: 907–916

    Article  PubMed  CAS  Google Scholar 

  13. Hanazaki K, Kuroda T, Wakabayashi M, Sodeyama H, Yokoyama S, Kusama J (1998) Hepatic metastasis from esophageal cancer treated by surgical resection and hepatic arterial infusion chemotherapy. Hepatogastroenterology 45: 201–205

    PubMed  CAS  Google Scholar 

  14. Hansen PD, Rogers S, Corless CL, Swanstrom LL, Siperstien AE (1999) Radiofrequency ablation lesions in a pig liver model. J Surg Res 87: 114–121

    Article  PubMed  CAS  Google Scholar 

  15. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, Fong Y (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121: 625–632

    Article  PubMed  CAS  Google Scholar 

  16. Jaques DP, Coit DG, Casper ES, Brennan MF (1995) Hepatic metastases from soft tissue sarcoma. Ann Surg 221: 392–397

    PubMed  CAS  Google Scholar 

  17. Machi J (2001) Radiofrequency ablation for multiple hepatic metastases. Ann Surg Oncol 8: 379–380

    PubMed  CAS  Google Scholar 

  18. Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB (1995) Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 76: 1120–1125

    PubMed  CAS  Google Scholar 

  19. Rose DM, Allegra DP, Bostick PJ, Foshag LJ, Bilchik AJ (1999) Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies. Am Surg 65: 1009–1014

    PubMed  CAS  Google Scholar 

  20. Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL (2001) Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 136: 950–955

    PubMed  CAS  Google Scholar 

  21. Schwartz SI (1995) Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg 19: 72–75

    Article  PubMed  CAS  Google Scholar 

  22. Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, Meric F, Hortobagyi GN (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8: 241–251

    Article  PubMed  Google Scholar 

  23. Siperstein A, Garland A, Engle K, Rogers S, Berber E, Foroutani A, String A, Ryan T, Ituarte P (2000) Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 7: 106–113

    Article  PubMed  CAS  Google Scholar 

  24. Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T (2000) Laparoscopic radiofrequency ablation of primary and metastatic liver tumors: technical considerations. Surg Endosc 14: 400–405

    Article  PubMed  CAS  Google Scholar 

  25. Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A (1997) Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 122: 1147–1154, discussion 1154–1155

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery/A 80, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    E. Berber, E. Ari, N. Herceg & A. Siperstein

Authors
  1. E. Berber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Ari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Herceg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Siperstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Siperstein.

Additional information

Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting, Fort Lauderdale, FL, USA, 13–16 April 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berber, E., Ari, E., Herceg, N. et al. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc 19, 1613–1617 (2005). https://doi.org/10.1007/s00464-005-0236-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-005-0236-0

Keywords

Search

Navigation